VivoSeq
Other

Women of Reproductive Age

0

Pipeline Programs↗

2

Active Trials↗

1

Companies Involved↗

Women of Reproductive Age is an early-stage landscape with 0 programs across 1 company. The most active players are Teva.

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Teva logo

Teva

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

4

clinical trials

Active, not recruiting2 · 50%
Completed1 · 25%
Unknown status1 · 25%

Clinical Trials

Trial Activity

A Study to Evaluate the Pharmacokinetics (PK) of Medroxyprogesterone Acetate Following an Injection of TV-46046 in Healthy Women of Reproductive Age
Completed·Teva logoTeva·Phase 1·NCT04682353·60 enrolled
The Effect of HPV Vaccine on Menstrual Cycle in Women of Reproductive Age
Unknown status·SSun Yat-sen University·N/A·NCT05838157·600 enrolled
Urogenital Infections in Women of Reproductive Age and the Activity of 4-Thiazolidinone Derivatives Against Pathogens
Active, not recruiting·—·Phase 1·NCT06616168·200 enrolled
Short-course Benznidazole Treatment to Reduce Trypanosoma Cruzi Parasitic Load in Women of Reproductive Age
Active, not recruiting·—·Phase 3·NCT03672487·273 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)